Company profile
ThromBio
ThromBio is a drug discovery company whose mission is to advance the global standard of care for the treatment of stroke
- Industry
- Biotechnology Research
- Employees
- 12
- Founded
- 2020
ThromBio company summary
ThromBio is a company in the Biotechnology Research industry, founded in 2020. On LinkedIn the company has around 12 employees. Its listed specialties include biotechnology, biotechnology research, reasearch in stroke, stroke drug, Thrombio holdings.
What technology does ThromBio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ThromBio
ThromBio is a drug discovery company whose mission is to advance the global standard of care for the treatment of stroke using novel anti-thrombotic drugs with unprecedented safety and efficacy. Leadership: ThromBio’s programme is driven by international leaders in drug discovery & development, experimental biomedicine, global clinical trials capability and commercialisation. Our Lead Candidate: TBO-309 TBO-309 represents an Australian drug development success story, that has resulted in a novel antiplatelet compound with truly remarkable properties. Lead Indications: Acute Ischaemic stroke remains the second largest cause of death and disability globally, with 85% of all strokes caused by blood clots that block blood flow to the brain. TBO-309 is currently being trialled in patients in Phase II clinical trials, as an adjunct to thrombolysis (STARS). Publications: ThromBio’s technology is built around state-of-the-art science and technology, published by internationally recognised leaders in the field of drug discovery & and experimental biomedicine. Media: ThromBio’s technology has received global attention for its breakthrough scientific studies. Contact us on social@thrombio.com.au or for more information look at our website.
Specialties
Compare companies similar to ThromBio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ThromBio thrombio.com.au | Biotechnology Research | 12 | 2020 | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ThromBio
What does ThromBio do?
ThromBio is a drug discovery company whose mission is to advance the global standard of care for the treatment of stroke using novel anti-thrombotic drugs with unprecedented safety and efficacy. Leadership: ThromBio’s programme is driven by international leaders in drug discovery & development, experimental biomedicine, global clinical trials capability and commercialisation. Our Lead Candidate: TBO-309 TBO-309 represents an Australian drug development success story, that has resulted in a novel antiplatelet compound with truly remarkable properties. Lead Indications: Acute Ischaemic stroke remains the second largest cause of death and disability globally, with 85% of all strokes caused by blood clots that block blood flow to the brain. TBO-309 is currently being trialled in patients in Phase II clinical trials, as an adjunct to thrombolysis (STARS). Publications: ThromBio’s technology is built around state-of-the-art science and technology, published by internationally recognised leaders in the field of drug discovery & and experimental biomedicine. Media: ThromBio’s technology has received global attention for its breakthrough scientific studies. Contact us on social@thrombio.com.au or for more information look at our website.
How many employees does ThromBio have?
ThromBio has around 12 employees on LinkedIn.
When was ThromBio founded?
ThromBio was founded in 2020.
Build a lead list from companies like ThromBio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.